Atlas Trials

Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers

Clinical trial NCT03694912 · UNKNOWN

Trial details

NCT number
NCT03694912
Sponsor
Yonsei University
Status
UNKNOWN
Study type
OBSERVATIONAL
Clear Renal Cell Cancer (< 7cm Size)
Start date
2018-11-01
Primary completion
2023-09-22
Enrollment
426

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.